Hepatitis C: FDA public meeting on peginterferon plus ribavirin, Nov. 14.
出版信息
AIDS Treat News. 2002 Oct 18(384):5.
PMID:12434764
Abstract
摘要
相似文献
1
Hepatitis C: FDA public meeting on peginterferon plus ribavirin, Nov. 14.
AIDS Treat News. 2002 Oct 18(384):5.
2
Ribavirin approved with a big fat price.
Notes Undergr. 1998 Sep-Oct(No 37):10-1.
3
Ribavirin approved for hepatitis C combination treatment.
AIDS Treat News. 1998 Jun 19(No 297):7.
4
Hepatitis C virus infection.
N Engl J Med. 2001 Nov 8;345(19):1425-6; author reply 1427-8.
5
6
Hepatitis drug gets approval for coinfection treatment.
AIDS Patient Care STDS. 2005 May;19(5):351. doi: 10.1089/apc.2005.19.350.
7
Hepatitis C: new treatment overview.
AIDS Treat News. 1998 Sep 4(302):5-6.
8
[PEG-interferon alfa 2a against hepatitis C. Better as the standard therapy].
MMW Fortschr Med. 2001 Nov 1;143(44):58.
9
Ribavirin and chronic hepatitis C infection.
FDA Consum. 2001 Sep-Oct;35(5):3.
10
FDA approves Pegasys and Copegus for hepatitis C in patients with HIV co-infection.
Hopkins HIV Rep. 2005 May;17(3):15.
Zotero 插件